ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO985

A Novel Mouse Model: Authentic Reproduction of Human CKD

Session Information

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms


  • Deng, Qiwen, Stanford University School of Medicine, Stanford, California, United States
  • Wernig, Gerlinde, Stanford University School of Medicine, Stanford, California, United States

Animal models are vital for understanding chronic kidney disease (CKD) pathogenesis and developing effective treatments. However, existing models fail to accurately replicate typical changes in human CKD. We present a novel mouse model faithfully recapitulating key aspects of human chronic kidney diseases.


We employed the Pax8-rtTA transgenic mouse model with high expression of the reverse tetracycline-dependent transactivator (rtTA) in kidney tubules under the control of the Pax8 promoter. Through crossing Pax8-rtTA mice with tetracycline-responsive Jun mice, an inducible CKD-JUN model was established, resulting in Jun overexpression specifically in kidney tubules upon doxycycline administration. Control mice were generated without doxycycline or Jun expression. Ten-week-old mice received continuous doxycycline (0.5 mg/ml) in their drinking water for 2 or 12 weeks. Body weight and kidney size were measured. Blood urea nitrogen (BUN) and serum creatinine were determined. Kidney tissue was subjected to H&E, PAS, and Trichrome staining to evaluate histological changes. Renal inflammation was evaluated through Luminex analysis of cytokine secretion in serum and kidney tissue supernatants, along with assessment of immune cell infiltration.


Following a 2-week induction, histological analysis confirmed acute tubular necrosis in CKD-JUN mice, validating early tubular injury due to Jun induction. After a 12-week induction, both male and female CKD-JUN mice exhibited stable kidney impairment, with males showing a higher propensity for chronic kidney injury and faster CKD progression. CKD-JUN mice displayed decreased body weight, reduced kidney size, elevated BUN and creatinine levels indicative of renal function failure, increased pro-fibrotic inflammatory cytokines in serum and kidney tissue supernatants, and histological signs of glomerular hypertrophy, tubular dilation, interstitial fibrosis, and inflammatory cell infiltration. Other organs in CKD-JUN and Control mice showed no significant differences, confirming the kidney-specific nature of this model. These findings closely resemble characteristic renal abnormalities observed in human CKD.


Our CKD-JUN mouse model faithfully recapitulates essential clinical and histological characteristics of human CKD, making it a reliable and invaluable tool for studying CKD mechanisms and evaluating therapeutic interventions.